The purpose of this study was to examine the effect of low- vs. high-intensity resistance exercise on lipid peroxidation. In addition, the role of muscle oxygenation on plasma malondialdehyde (MDA) concentrations was explored. Eleven experienced resistance trained male athletes (age: 20.8 +/- 1.3 years; weight: 96.2 +/- 14.4 kg; height: 182.4 +/- 7.3 cm) performed 4 sets of the squat exercise using either a low-intensity, high-volume (LI; 15 repetitions at 60% 1 repetition maximum [1RM]) or high-intensity, low-volume (HI; 4 repetitions at 90% 1RM load). Venous blood samples were obtained before the exercise (PRE), immediately following the exercise (IP), and 20 (20P) and 40 minutes (40P) postexercise. Continuous wave near-infrared spectroscopy was used to measure muscle deoxygenation in the vastus lateralis during exercise. Deoxygenated Hb/Mb change was used to determine reoxygenation rate during recovery. No difference in MDA concentrations was seen between LI and HI at any time. Significant correlations were observed between plasma MDA concentrations at IP and the half-time recovery (T1/2 recovery) of muscle reoxygenation (r = 0.45) and between T1/2 recovery and the area under the curve for MDA concentrations (r = 0.44). Results suggest that increases in MDA occur independently of exercise intensity, but tissue acidosis may have a larger influence on MDA formation.
The impact of long-term opioid exposure on the embryonic brain is crucial to healthcare due to the surging number of pregnant mothers with an opioid dependency. Current studies on the neuronal effects are limited due to human brain inaccessibility and cross-species differences among animal models. Here, we report a model to assess cell-type specific responses to acute and chronic fentanyl treatment, as well as fentanyl withdrawal, using human induced pluripotent stem cell (hiPSC)-derived midbrain organoids. Single cell mRNA sequencing (25,510 single cells in total) results suggest that chronic fentanyl treatment arrests neuronal subtype specification during early midbrain development and alters the pathways associated with synaptic activities and neuron projection. Acute fentanyl treatment, however, increases dopamine release but does not induce significant changes in gene expressions of cell lineage development. To date, our study is the first unbiased examination of midbrain transcriptomics with synthetic opioid treatment at the single cell level.
As part of the Synthetic Yeast 2.0 (Sc2.0) project, we designed and synthesized synthetic chromosome I. The total length of synI is ~21.4% shorter than wild-type chromosome I, the smallest chromosome in Saccharomyces cerevisiae. SynI was designed for attachment to another synthetic chromosome due to concerns of potential instability and karyotype imbalance. We used a variation of a previously developed, robust CRISPR-Cas9 method to fuse chromosome I to other chromosome arms of varying length: chrIXR (84 kb), chrIIIR (202 kb) and chrIVR (1 Mb). All fusion chromosome strains grew like wild-type so we decided to attach synI to synIII. Through the investigation of three-dimensional structures of fusion chromosome strains, unexpected loops and twisted structures were formed in chrIII-I and chrIX-III-I fusion chromosomes, which depend on silencing proteinSir3. These results suggest a previously unappreciated 3D interaction between HMR and the adjacent telomere. We used these fusion chromosomes to show that axial element Red1 binding in meiosis is not strictly chromosome size dependent even though Red1 binding is enriched on the three smallest chromosomes in wild-type yeast, and we discovered an unexpected role for centromeres in Red1 binding patterns.
it is important to explore the behavior change techniques (BCTs) employed and their contribution to pooled effectiveness. This paper aimed to estimate the pooled effectiveness of OAD adherence-enhancing interventions and identify BCTs applied that had a modifying effect on the pooled estimate of effectiveness. Methods: We performed a systematic review and meta-analysis of RCTs conducted to evaluate the effectiveness of adherence-enhancing interventions targeting adults receiving OADs. Articles were searched using PubMed, Embase, Psych-Info, the Cochrane Library, CINAHL PLUS, Current Contents Connect and Web of science, and included articles references and relevant review articles. Two authors independently selected eligible articles and coded study details including BCTs applied in intervention and control groups. Each intervention's effectiveness (effect size) was estimated using Hedges's g. Pooled effectiveness and its heterogeneity (Higgins I 2 ) were estimated using a random effect model. For BCTs applied in intervention but not in control groups, we assessed their modifying effect on the pooled effectiveness by comparing interventions in which a specific BCT was applied with those in which it was not. Results: A total of 10 studies were included. Globally, the pooled effectiveness (g) was 0.21 (95%CI= -0.05-0.47; I 2 = 82%). Out of eight BCTs analysed, cope with side-effects (P= 0.003) and general intention formation (P= 0.006) had a modifying effect on the pooled effectiveness. The pooled effectiveness of interventions, in which cope with side-effects was applied, was moderate (g= 0.64; 95%CI= 0.31-0.96; I 2 = 56%). ConClusions: Globally, effectiveness of interventions offered in intervention groups was almost equivalent to that of those offered in control groups. However, interventions that include helping people to cope with side-effects, when this was not done for control patients, are particularly effective in improving adherence to OAD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.